Skip to content

Comparison of effect of two uterotonic drugs on hemodynamics and bleeding after cesarean section under spinal anesthesia.

Hemodynamic effects of Oxytocin and Carbetocin during elective lower segment cesarean section under spinal anesthesia: a double blinded randomized controlled study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071700
Enrollment
60
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Carbetocin: After delivery of baby and clamping of umbilical cord, measurement of hemodynamic parameters will be done and denoted as T0. 100 mcg carbetocin 10 ml dilution with NS/ RL o

Sponsors

Department of Anesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy pregnant woman under going elective lower segment cesarean section at term under spinal anesthesia concerning to be part of study. 2. Patients aged between 18 to 35 years of age.

Exclusion criteria

Exclusion criteria: 1. Women with known sensitivity to heat-stable carbetocin or oxytocin 2. Pregnancy with high risk of PPH 3. Pregnancy with other comorbidities

Design outcomes

Primary

MeasureTime frame
To compare changes in maternal hemodynamic parameters (heart rate, systolic and diastolic blood pressure, mean arterial pressure, ST index and O2 saturation) with use of oxytocin and carbetocin in elective lower segment caesarean section.Timepoint: After drug administration, hemodynamic parameters will be recorded at 0, 1, 3, T5, T10, T15, and T30 mins.

Secondary

MeasureTime frame
To compare the incidence of intraoperative & postoperative feeling of warmth, chest pain, shortness of breath, palpitations, flushing, headache, nausea/ vomiting & chest discomfort.Timepoint: Patient will be assessed at 10,20,30, 60 minutes post operatively.;To compare uterine tone & need of additional uterotonics with use of oxytocin & carbetocin.Timepoint: Uterine tone will be assessed after 20 minutes of drug administration.

Countries

India

Contacts

Public ContactDr Mathangi Krishnakumar

St John’s medical college hospital

rashmi172007@rediffmail.com7760713968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026